A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Non-Small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of California Irvine, Orange, California, United States

  • Orchard Healthcare Research Inc., Skokie, Illinois, United States

  • Karmanos Cancer Institute, Detroit, Michigan, United States

  • Detroit Clinical Research Center, Farmington Hills, Michigan, United States

  • Morristown Medical Center, Morristown, New Jersey, United States

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • Oncology Hematology Care Clinical Trials LLC, Cincinnati, Ohio, United States

  • Providence Portland Medical Center, Portland, Oregon, United States

  • University Of Nebraska Medical Center, Portland, Oregon, United States

  • Lifespan Cancer Institute, Providence, Rhode Island, United States

  • Prairie Lakes Healthcare System, Watertown, South Dakota, United States

  • University of Tennessee Medical Center, Knoxville, Tennessee, United States

  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville, Tennessee, United States

  • Tennessee Oncology, Nashville, Tennessee, United States

  • BRCC/Oncology & Hematology Associates of SW Virginia, Blacksburg, Virginia, United States

  • Oncology Clinical Research Center, Cachoeiro de Itapemirim, Espírito Santo, Brazil

  • Instituto Mario Penna, Belo Horizonte, Minas Gerais, Brazil

  • Instituto Sul Mineiro De Oncologia LTDA, Pouso Alegre, Minas Gerais, Brazil

  • Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco, Brazil

  • Liga Norte Riograndense Contra o Cancer, Natal, Rio Grande do Norte, Brazil

  • Hospital Mae de Deus Integrated Oncology Center, Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital Sao Lucas da PUCRS, Porto Alegre, Rio Grande do Sul, Brazil

  • Ynova Pesquisa Clinica, Florianópolis, Santa Catarina, Brazil

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, São José do Rio Preto, São Paulo, Brazil

  • Unimed Sorocaba, Sorocaba, São Paulo, Brazil

  • Hospital Alemao Oswaldo Cruz, São Paulo, Brazil

  • CHU Rennes, Rennes, Brittany Region, France

  • Centre Hospitalier Intercommunal Toulon - CHITS, Toulon, Var, France

  • Centre Hospitalier de la Cote Basque, Bayonne, France

  • Clinique Belharra, Bayonne, France

  • CHU Grenoble Alpes, Grenoble, France

  • Montpellier Academic Hospital, Montpellier, France

  • Institut Curie, Paris, Île-de-France Region, France

  • Klinikum Kassel GmbH, Hauttumorzentrum, Kassel, Hesse, Germany

  • University Medicine Gottingen, Göttingen, Lower Saxony, Germany

  • University of Leipzig, Leipzig, Saxony, Germany

  • University Hospital RWTH Aachen, Aachen, Germany

  • Catalan Instituye of Oncology Badalona, Badalona, Barcelona, Spain

  • Hospital Valdecilla, Santander, Cantabria, Spain

  • Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain

  • Clinica Universidad de Navarra, Pamplona, Navarre, Spain

  • MD Anderson Cancer Center, Madrid, Spain

  • Hospital Universitario Clinico San Carlos, Madrid, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Universitario HM Sanchinarro, Madrid, Spain

  • Hospital Virgen del Rocio, Seville, Spain

  • Hospital Clinico Universitario Valencia, Valencia, Spain

  • Consorci Hospital General Universitario de Valencia, Valencia, Spain

  • Hospital Clinico Lozano Blesa, Zaragoza, Spain

  • Florya Medical Park Hospital, Istanbul, Turkey (Türkiye)

מובילי המחקר
  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals